AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 203 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,892,610 | +73.0% | 213,000 | +113.0% | 0.99% | +79.6% |
| Q3 2022 | $2,828,000 | +206.4% | 100,000 | +400.0% | 0.55% | +107.2% |
| Q3 2021 | $923,000 | -44.2% | 20,000 | -33.3% | 0.26% | -41.8% |
| Q2 2021 | $1,653,000 | -25.6% | 30,000 | -30.2% | 0.46% | -28.3% |
| Q1 2021 | $2,221,000 | -31.7% | 43,000 | -42.7% | 0.64% | -34.3% |
| Q4 2020 | $3,250,000 | -22.6% | 75,000 | -37.5% | 0.97% | -24.7% |
| Q3 2020 | $4,200,000 | -47.6% | 120,000 | -20.0% | 1.28% | -46.5% |
| Q2 2020 | $8,022,000 | +50.7% | 150,000 | 0.0% | 2.40% | +2.5% |
| Q1 2020 | $5,322,000 | -41.3% | 150,000 | -21.1% | 2.34% | -33.7% |
| Q4 2019 | $9,073,000 | – | 190,000 | – | 3.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |